Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis

Hoogerwerf, 1999, Pain: the overlooked symptom in gastroparesis, Am J Gastroenterol, 94, 1029, 10.1111/j.1572-0241.1999.01008.x Malagelada, 1980, Gastric motor abnormalities in diabetic ands post-vagotomy gastroparesis: effect of metoclopramide and bethanechol, Gastroenterology, 78, 286, 10.1016/0016-5085(80)90578-8 Camilleri, 1986, Relationship between impaired gastric emptying and abnormal gastrointestinal motility, Gastroenterology, 91, 94, 10.1016/0016-5085(86)90444-0 Mearin, 1986, Pyloric dysfunction in diabetics with recurrent nausea and vomiting, Gastroenterology, 90, 1919, 10.1016/0016-5085(86)90262-3 Zarate, 2003, Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management, Gut, 52, 966, 10.1136/gut.52.7.966 Chey, 1999, Gastroduodenal motility disorders and gastroparesis, 235 Sturm, 1999, Prokinetics in patients with gastroparesis: a systemic analysis, Digestion, 60, 422, 10.1159/000007687 Erbas, 1993, Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis, Diabetes Care, 16, 1511, 10.2337/diacare.16.11.1511 Soykan, 1997, The effect of chronic oral domperidone on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis, Am J Gastroenterol, 92, 976 Jankovic, 1991, Therapeutic uses of botulinum toxin, N Engl J Med, 324, 1186, 10.1056/NEJM199104253241707 Schiavo, 1993, Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin, J Biol Chem, 268, 11516, 10.1016/S0021-9258(19)50230-7 James, 2003, Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle, Am J Physiol Gastrointest Liver Physiol, 285, 291, 10.1152/ajpgi.00296.2002 Gupta, 2002, Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report, Gastrointest Endosc, 56, 770, 10.1016/S0016-5107(02)70140-5 Pasricha, 1996, Botulinum toxin for achalasia: long term outcome and predictors of response, Gastroenterology, 110, 1410, 10.1053/gast.1996.v110.pm8613045 Brisinda, 1999, A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure, N Engl J Med, 341, 65, 10.1056/NEJM199907083410201 Miller, 2002, Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction, Am J Gastroenterol, 97, 1640, 10.1111/j.1572-0241.2002.05821.x Ezzeddine, 2002, Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis, Gastrointest Endosc, 55, 920, 10.1067/mge.2002.124739 Miller, 2002, Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle, Am J Gastroenterol, 97, 1653, 10.1111/j.1572-0241.2002.05823.x Lacy, 2002, Botulinum toxin for the treatment of gastroparesis: a preliminary report, Am J Gastroenterol, 97, 1548, 10.1111/j.1572-0241.2002.05741.x Arts, 2003, Effect of intrapyloric injection of botulinum toxin on gastric emptying and meal-related symptoms in gastroparesis, Gastroenterology, 124, A431, 10.1016/S0016-5085(03)80264-0 Guo, 2001, Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis, Dig Dis Sci, 46, 24, 10.1023/A:1005697422454 Revicki, 2003, Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index, Aliment Pharmacol Ther, 18, 141, 10.1046/j.1365-2036.2003.01612.x Wilks, 2002, Building and applying logistic regression models, 214 Snape, 1982, Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial, Ann Intern Med, 96, 444, 10.7326/0003-4819-96-4-444 Perkel, 1980, Metoclopramide therapy in fifty-five patients with delayed gastric emptying, Am J Gastroenterol, 74, 231 Camilleri, 1989, Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction, Gastroenterology, 96, 704 Richards, 1993, Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis, Dig Dis Sci, 38, 811, 10.1007/BF01295905 Kolbasnik, 1999, Long term efficacy of botulinum toxin in classical achalasia: a prospective study, Am J Gastroenterol, 94, 3434, 10.1111/j.1572-0241.1999.01605.x Pasricha, 1995, Intrasphincteric botulinum toxin for the treatment of achalasia, N Engl J Med, 332, 774, 10.1056/NEJM199503233321203 Harris, 1991, Histologic features of human orbicularis oculi treated with botulinum A toxin, Arch Ophthalmol, 109, 393, 10.1001/archopht.1991.01080030095046 Patti, 1999, Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia, Dig Dis Sci, 44, 2270, 10.1023/A:1026660921776 Herrmann, 2004, Clinical impact of antibody formation to botulinum toxin A in children, Ann Neurol, 55, 732, 10.1002/ana.20098